Keyphrases
Breast Cancer
83%
Indonesia
73%
Breast Cancer Patients
72%
Neoadjuvant Chemotherapy
40%
Referral Hospital
33%
Clinical Response
32%
Locally Advanced Breast Cancer
26%
South-East Asia
25%
Papillary Thyroid Carcinoma
23%
COVID-19 Pandemic
23%
Metastatic Triple-negative Breast Cancer
23%
Forkhead Box P3 (FOXP3)
22%
Indonesian
22%
Low-middle Income Countries
22%
CD-8
21%
Prospective Cohort Study
19%
Malignancy
18%
Jakarta
18%
Prognostic Factors
18%
Immunohistochemistry
17%
Early Breast Cancer
17%
Cancer Surgery
17%
Association of Southeast Asian Nations (ASEAN)
17%
CD163
17%
Multicenter Cohort Study
16%
Middle-income Countries
16%
Metastasis
16%
Vascular Endothelial Growth factor-C (VEGF-C)
15%
Randomized Controlled Trial
15%
Multicenter Cross-sectional Study
15%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
15%
Targeted Sequencing
15%
BRAF V600E
15%
Lymphedema Treatment
15%
Lymph Node Metastasis
15%
Low-income
15%
Financial Crashes
14%
Oncology
14%
Triple-negative Breast Cancer
13%
Breast Cancer Risk
13%
Melatonin
12%
Antitumor
12%
Pro-tumor
12%
Cancer Patients
12%
Patients with Breast Cancer
11%
T Cells
11%
Chemotherapy
11%
Locally Advanced
11%
Core Needle Biopsy
11%
Axillary Lymph Node Dissection
11%
Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
62%
Patient Referral
34%
Neoplasm
27%
Prospective Cohort Study
27%
Papillary Thyroid Cancer
25%
Neoadjuvant Chemotherapy
25%
COVID-19
23%
Locally Advanced Breast Cancer
23%
Lymph Duct
22%
Cancer
22%
Health Care Cost
20%
Cross Sectional Study
20%
Metastatic Carcinoma
18%
Prognostic Factor
18%
Cancer Surgery
17%
Immunohistochemistry
17%
Low and Middle Income Countries
17%
Lymph Node Metastasis
16%
Vasculotropin C
15%
Triple Negative Breast Cancer
15%
Lymphedema
15%
Echography
15%
Oncology
15%
Household
15%
Neck
14%
Retroperitoneal Lymph Node Dissection
13%
Axillary Lymph Node
12%
Cancer Therapy
11%
Odds Ratio
11%
Surgical Technique
11%
Thyroidectomy
10%
Diseases
10%
Biopsy Technique
10%
Lymph Node
10%
Histopathology
9%
Thyroid Nodule
9%
Cancer Staging
9%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
9%
T Lymphocyte
9%
Therapy Delay
8%
Cell Marker
7%
Solid Malignant Neoplasm
7%
Elderly Patient
7%
Chronic Kidney Disease
7%
Quality of Life
7%
Observational Study
7%
Tyrosine-Kinase Inhibitor
7%
Abdominal Cancer
7%
Insulin Resistance
7%